| abstract |
A medicament for reducing the neuronal damage due to the NMDA receptor in a mammal, comprising a nitric oxide-generating compound or a physiologically acceptable salt of said compound, in a concentration effective for causing said reduction. A medicament for reducing neuronal damage due to the NMDA receptor in a mammal comprising nitroprusside, nitroglycerin or a derivative of one of these compounds, in a concentration effective for causing said reduction, is also described. |